Advanced Strategies for Precision Therapy in Urinary Cancers
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 30 September 2026 | Viewed by 967
Editors
Interests: nano medicine; drug delivery; cancer therapy; phototherapy; mitochondria-targeting
2. Stony Brook Cancer Center, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA
Interests: drug delivery; microrobots; nano medicine; bladder cancer; drug development
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Urological malignancies, including renal cell carcinoma, bladder cancer, and prostate cancer, present a complex landscape of metabolic heterogeneity and distinct anatomical barriers. Despite the success of immune checkpoint inhibitors and antibody-drug conjugates (ADCs), clinical outcomes are often limited by the urothelial-blood barrier, high interstitial fluid pressure, and the highly immunosuppressive tumor microenvironment (TME). This Special Issue focuses on the engineering of functionalized delivery systems and molecular therapeutics designed to bypass these hurdles. We invite submissions on the following topics: (1) stimuli-responsive drug delivery systems designed to navigate urological physiological barriers; (2) next-generation biologics, including mRNA and circular RNA platforms for targeted gene modulation; (3) advanced theranostic strategies utilizing radioligand therapy (e.g., PSMA-targeted agents) and multimodal imaging; (4) strategies to overcome immunosuppression within the urological tumor microenvironment. Our goal is to collect original research that provides practical, high-efficiency solutions, as well as high-quality reviews that offer comprehensive insights and future perspectives on the precision management of urinary cancers.
Dr. Menghuan Tang
Dr. Zhaoqing Cong
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- urological oncology
- precision drug delivery system
- nanomaterials
- stimuli-responsive delivery
- immunotherapy
- radioligand therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
